Tate & Lyle PLC

Public consensus   -   Last updated 15/10/25

Contributors

  • 12 H1 FY26 based on
  • 12 FY26 based on
  • 12 FY27 based on
Reporting currency: GBP
Reporting unit: Millions
H1 FY26
CONSENSUS
15/10/25
FY26
CONSENSUS
15/10/25
FY27
CONSENSUS
15/10/25
Group Income Statement (£m)
Revenue (New segments)
Americas
503
997
1,017
Europe, Middle East and Africa
316
630
642
Asia Pacific
189
372
384
Revenue - Group
1,007
1,999
2,046
Adjusted EBITDA (New segments)
Americas
134
268
280
Europe, Middle East and Africa
51
101
108
Asia Pacific
24
50
54
Adjusted EBITDA - Group
209
418
442
Less: Depreciation and adjusted amortisation
(68)
(135)
(137)
Adjusted operating profit
141
283
306
Net finance expense
(22)
(43)
(40)
Adjusted profit before tax
119
240
266
Adjusted Profit after Tax (pre excepts and amort)
91
183
202
Average diluted shares (m) (including impact of share buyback)
447.3
449.1
447.6
Adjusted diluted EPS (p)
20.3
40.7
45.2
Dividend/Share (p)
6.2
19.6
20.3
$/£ assumption (average rate)
1.34
1.34
1.34
€/£ assumption (average rate)
1.17
1.16
1.15
Group Cash Flow Statement (£m)
Adjusted Free cash flow (before exceptional cash flows)
72
146
212
Other cash flows in the year
Closing net debt
(952)
(901)
(804)

Disclaimer

Tate & Lyle PLC (“Tate & Lyle”) invites registered sell-side analysts that monitor Tate & Lyle’s stock to submit their forecasts to an external, web-based tool managed
by Vuma Financial Limited (“Vuma”), a company independent of Tate & Lyle.

The web-based tool generates an aggregation of publicly available forecasts collated exclusively by Vuma, but only on the basis of information submitted by those
analysts who choose to participate. The arithmetic average of the constituent analyst forecasts is known as “Consensus”. Vuma has no access to Tate & Lyle's
internal forecasts, budgets or any other information which is not publicly available.

Tate & Lyle has not commented on individual forecasts nor does it intend to do so in the future. Tate & Lyle assumes no obligation to update or revise such
information and nothing in this analysis should be taken as a recommendation to buy or sell shares in Tate & Lyle or to take any other action or place any reliance
on the analysis.

Consensus figures are provided for information only, and neither Tate & Lyle nor any of its subsidiary undertakings nor any director, officer or employee of
Tate & Lyle or any of its subsidiary undertakings accepts any responsibility for the accuracy or completeness of forecasts used in this analysis and therefore shall
have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in this analysis.